Device Connectivity Set to Drive Major Care Change for Millions of COPD Patients
February 9, 2017 | ABI ResearchEstimated reading time: 1 minute
Chronic respiratory diseases—asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD)—affect up to one billion patients globally. While in the past, clinicians monitored patients’ vitals through regular checkups, new wearable technology now allows them to track this information remotely. ABI Research forecasts device connectivity will drive new chronic respiratory disease wearable form factors, with shipments to grow from three million shipments in 2017 to 12 million in 2022.
COPD, alone, costs U.S. healthcare systems $50 billion per year. ABI Research forecasts the U.S. will spend the most on chronic respiratory disease wearables, accounting for $6 million in 2022 of $21 million in global market revenues. Following the U.S., Europe and the Asia Pacific will also see high adoption rates. As the nascent market gains momentum, the devices will gradually shift from wireless finger-clips to wrist-worn devices.
“Wrist-worn chronic respiratory disease wearables are the ideal form factor, because they allow patients to carry out daily activities uninterrupted while collecting data continuously and in real time to note any subtle fluctuations in oxygen levels,” says Stephanie Lawrence, Research Analyst at ABI Research. “Finger-clip devices must be manually attached and activated throughout the day to provide one-off readings. Though they still provide more information than pulse oximeters in a clinical setting, finger-clip devices often miss subtle fluctuations that could indicate worsening conditions.”
Non-invasive medical monitoring solutions developer Nonin Medical’s latest wrist-worn pulse oximeter—WristOx 2, Model 3150—measures patients’ oxygen saturation and pulse rates, transmitting the data using Bluetooth 2.0. Additionally, medical device manufacturer and startup Oxitone Medical recently released its Oxitone wrist pulse oximeter that continuously monitors blood oxygen levels and sends the data to an app via embedded Bluetooth Smart.
Challenges vendors need to overcome as the market develops include meeting medical regulatory standards. The mandatory standards are critical, as they are clear proof that the device is an effective and accurate form of monitoring a patient’s condition. As obtaining medical regulation is a lengthy process, manufacturers must consider it in the early design stage as the global market develops.
Suggested Items
SPEA Expands in Southeast Asia with New Subsidiary in Thailand
05/17/2024 | SPEASPEA, a global leader in automatic test equipment for the manufacturing of semiconductor, microelectronic and electronic devices, today announced the opening of its new subsidiary in Thailand. This expansion marks a significant step forward in SPEA's commitment to serving the growing Southeast Asian microchip and electronics market with leading-edge manufacturing machinery and equipment.
PCB Market Size to Grow by $29.06B from 2024-2028
05/17/2024 | PRNewswireThe global printed circuit board (PCB) market size is estimated to grow by USD 29.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.6% during the forecast period.
AT&S 2024/25 on Growth Course Again
05/17/2024 | AT&SAT&S operated in a challenging market environment in the financial year 2023/24. After a strong second quarter, demand was relatively weak again in some market segments in the second half of the financial year.
Shipments of OLED Monitors Hit 200,000 Units in 1Q24, Annual Forecast to Reach 1.34 Million
05/17/2024 | TrendForceTrendForce’s latest report reveals a robust start to 2024 for OLED monitors, with shipments reaching approximately 200,000 units in the first quarter—marking a YoY growth of 121%.
Magnachip Celebrates the Grand Opening of Magnachip Technology Company in China
05/16/2024 | MagnachipMagnachip Semiconductor Corporation celebrated the opening ceremony of Magnachip Technology Company, Ltd. (MTC) yesterday at its headquarters located in Hefei, China. MTC is a subsidiary of Magnachip, established on December 20, 2023, to expand the Company’s display driver IC and power IC businesses in China.